骨标志物在骨质疏松症患者评估及随访中的临床应用：为何临床医生对这些标志物接受度不高？ - Suppr

Clinical utility of bone markers in the evaluation and follow-up of osteoporotic patients: why are the markers poorly accepted by clinicians?

作者信息

Stepan J J

机构信息

3rd Department of Internal Medicine, Faculty of Medicine, Charles University, and Centre for Metabolic Bone Diseases of the University Hospital, Prague, Czech Republic.

出版信息

J Endocrinol Invest. 2003 May;26(5):458-63. doi: 10.1007/BF03345203.

DOI:10.1007/BF03345203

PMID:12906375

Abstract

摘要

相似文献

Clinical utility of bone markers in the evaluation and follow-up of osteoporotic patients: why are the markers poorly accepted by clinicians?骨标志物在骨质疏松症患者评估及随访中的临床应用：为何临床医生对这些标志物接受度不高？

J Endocrinol Invest. 2003 May;26(5):458-63. doi: 10.1007/BF03345203.

Biochemical markers of bone metabolism in the assessment of osteoporosis: useful or not?骨代谢生化标志物在骨质疏松症评估中的作用：是否有用？

J Endocrinol Invest. 2003 May;26(5):464-71. doi: 10.1007/BF03345204.

[Parathyroid and bone. Effect of parathyroid hormone on bone quality].[甲状旁腺与骨骼。甲状旁腺激素对骨质量的影响]

Clin Calcium. 2007 Dec;17(12):1858-64.

[New bone density conservation agents for osteoporosis under research and development: Strontium ranelate].[正在研发的用于骨质疏松症的新型骨密度保护剂：雷奈酸锶]

Nihon Rinsho. 2007 Nov 28;65 Suppl 9:447-53.

Pharmacological topics of bone metabolism: recent advances in pharmacological management of osteoporosis.骨代谢的药理学主题：骨质疏松症药物治疗的最新进展

J Pharmacol Sci. 2008 Apr;106(4):530-5. doi: 10.1254/jphs.fm0070218.

[Outline of Guidelines 2004 for bone marker in osteoporosis].[2004年骨质疏松症骨标志物指南大纲]

Nihon Rinsho. 2007 Nov 28;65 Suppl 9:37-41.

Is bone mineral density predictive of fracture risk reduction?骨矿物质密度能否预测骨折风险降低？

Curr Med Res Opin. 2004 Mar;20(3):341-9. doi: 10.1185/030079903125003062.

[Role of bone histology in the determination of bone metabolism].[骨组织学在骨代谢测定中的作用]

Med Klin (Munich). 2003 Feb 15;98(2):111-2; author reply 113.

[Clinical utility of bone markers in the assessment of fracture risk].[骨标志物在骨折风险评估中的临床应用]

Nihon Rinsho. 2007 Nov 28;65 Suppl 9:259-63.

Use of bone turnover markers in the management of osteoporosis.骨转换标志物在骨质疏松症管理中的应用。

Curr Opin Endocrinol Diabetes Obes. 2018 Dec;25(6):366-372. doi: 10.1097/MED.0000000000000446.

本文引用的文献

Biochemical indices of bone turnover and the assessment of fracture probability.骨转换的生化指标与骨折概率评估

Osteoporos Int. 2002 Jul;13(7):523-6. doi: 10.1007/s001980200068.

Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting.I型胶原C末端肽血清浓度（血清CTx）的昼夜变化：性别、年龄、绝经状态、姿势、日光、血清皮质醇和禁食的影响

Bone. 2002 Jul;31(1):57-61. doi: 10.1016/s8756-3282(02)00791-3.

Effect of feeding on bone turnover markers and its impact on biological variability of measurements.喂养对骨转换标志物的影响及其对测量生物学变异的作用。

Bone. 2002 Jun;30(6):886-90. doi: 10.1016/s8756-3282(02)00728-7.

Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: the OFELY prospective study.I型胶原蛋白的消旋化和异构化与绝经后女性骨折风险：OFELY前瞻性研究

J Bone Miner Res. 2002 May;17(5):826-33. doi: 10.1359/jbmr.2002.17.5.826.

Six and twelve month changes in bone turnover are related to reduction in vertebral fracture risk during 3 years of raloxifene treatment in postmenopausal osteoporosis.在绝经后骨质疏松症患者接受雷洛昔芬治疗的3年期间，骨转换的6个月和12个月变化与椎体骨折风险降低相关。

Osteoporos Int. 2001;12(11):922-30. doi: 10.1007/s001980170020.

Interlaboratory variation of biochemical markers of bone turnover.骨转换生化标志物的实验室间差异。

Clin Chem. 2001 Aug;47(8):1443-50.

Markers of bone turnover for monitoring treatment of osteoporosis with antiresorptive drugs.用于监测抗吸收药物治疗骨质疏松症的骨转换标志物。

Osteoporos Int. 2000;11 Suppl 6:S66-76. doi: 10.1007/s001980070007.

Markers of bone turnover for the prediction of fracture risk.用于预测骨折风险的骨转换标志物。

Osteoporos Int. 2000;11 Suppl 6:S55-65. doi: 10.1007/s001980070006.

Prediction of bone loss in postmenopausal women.绝经后女性骨质流失的预测。

Osteoporos Int. 2000;11 Suppl 6:S45-54. doi: 10.1007/s001980070005.

Preanalytical variability of biochemical markers of bone turnover.骨转换生化标志物的分析前变异性

Osteoporos Int. 2000;11 Suppl 6:S30-44. doi: 10.1007/s001980070004.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical utility of bone markers in the evaluation and follow-up of osteoporotic patients: why are the markers poorly accepted by clinicians?

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

本文引用的文献